HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer.
| Image |  |
|---|---|
| Description | scientific article published on 22 November 2016 |
| Author/s |
author: Tarik Ghadban Ulrich Wellner |
| Publication date | March 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |